Want to see HK:2196 full AI Analyst Report?
Shanghai Fosun Pharmaceutical (Group) Co (2196) Income Statement
Shanghai Fosun Pharmaceutical (Group) Co Income Statement
Last quarter (Q3 2026), Shanghai Fosun Pharmaceutical (Group) Co's total revenue was $10.02B, an increase of 1.44% from the same quarter last year. In Q3, Shanghai Fosun Pharmaceutical (Group) Co's net income was $946.02M. See Shanghai Fosun Pharmaceutical (Group) Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 40.42B | $ 41.07B | $ 41.40B | $ 43.95B | $ 39.01B | |
| $ 20.16B | $ 19.70B | $ 19.68B | $ 20.78B | $ 18.78B | |
| $ 17.63B | $ 15.46B | $ 16.50B | $ 17.15B | $ 16.06B | |
| Depreciation and Amortization | $ 3.51B | $ 3.00B | $ 2.97B | $ 2.34B | $ 1.83B |
| $ 6.05B | $ 8.60B | $ 7.55B | $ 7.87B | $ 8.70B | |
| $ 2.54B | $ 4.25B | $ 3.31B | $ 8.30B | $ 6.31B | |
| $ 2.44B | $ -75.82M | $ -42.94M | $ -82.27M | $ -259.90M | |
| $ 4.98B | $ 4.17B | $ 3.26B | $ 4.57B | $ 6.05B | |
| $ 3.28B | $ 2.77B | $ 2.39B | $ 3.73B | $ 4.73B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.24 | $ 1.04 | $ 0.89 | $ 1.43 | $ 1.85 |
| Diluted EPS | $ 1.24 | $ 1.04 | $ 0.89 | $ 1.43 | $ 1.85 |
| Weighted Average Shares Outstanding | 2.65B | 2.67B | 2.67B | 2.61B | 2.56B |
| Weighted Average Shares Outstanding (Diluted) | 2.65B | 2.67B | 2.67B | 2.61B | 2.56B |
Currency in CNY
